Mesa Laboratories Operating Margin 2011-2025 | MLAB
Current and historical operating margin for Mesa Laboratories (MLAB) over the last 10 years. The current operating profit margin for Mesa Laboratories as of September 30, 2025 is 14.66%.
| Mesa Laboratories Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $0.25B | $0.02B | 6.10% |
| 2025-06-30 | $0.24B | $0.01B | 5.76% |
| 2025-03-31 | $0.24B | $0.02B | 7.05% |
| 2024-12-31 | $0.24B | $-0.26B | -107.14% |
| 2024-09-30 | $0.23B | $-0.26B | -114.47% |
| 2024-06-30 | $0.22B | $-0.27B | -118.83% |
| 2024-03-31 | $0.22B | $-0.27B | -125.93% |
| 2023-12-31 | $0.21B | 0 | 0.00% |
| 2023-09-30 | $0.21B | $0.00B | 1.40% |
| 2023-06-30 | $0.22B | $0.01B | 3.18% |
| 2023-03-31 | $0.22B | $0.00B | 1.37% |
| 2022-12-31 | $0.22B | $0.00B | 0.90% |
| 2022-09-30 | $0.22B | $0.00B | -1.79% |
| 2022-06-30 | $0.20B | $0.00B | -2.00% |
| 2022-03-31 | $0.19B | $0.00B | 2.16% |
| 2021-12-31 | $0.16B | $0.01B | 4.88% |
| 2021-09-30 | $0.14B | $0.01B | 7.69% |
| 2021-06-30 | $0.14B | $0.01B | 7.91% |
| 2021-03-31 | $0.13B | $0.01B | 8.96% |
| 2020-12-31 | $0.13B | $0.01B | 6.92% |
| 2020-09-30 | $0.13B | $0.01B | 4.69% |
| 2020-06-30 | $0.12B | $0.01B | 5.74% |
| 2020-03-31 | $0.12B | $0.01B | 6.78% |
| 2019-12-31 | $0.11B | $0.01B | 9.09% |
| 2019-09-30 | $0.11B | $0.01B | 13.33% |
| 2019-06-30 | $0.10B | $0.01B | 9.62% |
| 2019-03-31 | $0.10B | $0.01B | 9.71% |
| 2018-12-31 | $0.10B | $0.01B | 13.46% |
| 2018-09-30 | $0.10B | $0.00B | 2.97% |
| 2018-06-30 | $0.10B | $0.01B | 6.06% |
| 2018-03-31 | $0.10B | $0.00B | 3.09% |
| 2017-12-31 | $0.09B | $0.00B | 1.06% |
| 2017-09-30 | $0.09B | $0.02B | 15.96% |
| 2017-06-30 | $0.10B | $0.02B | 15.79% |
| 2017-03-31 | $0.09B | $0.02B | 17.20% |
| 2016-12-31 | $0.09B | $0.02B | 18.09% |
| 2016-09-30 | $0.09B | $0.02B | 18.89% |
| 2016-06-30 | $0.09B | $0.02B | 18.18% |
| 2016-03-31 | $0.09B | $0.02B | 20.00% |
| 2015-12-31 | $0.08B | $0.02B | 18.99% |
| 2015-09-30 | $0.08B | $0.02B | 19.48% |
| 2015-06-30 | $0.07B | $0.02B | 22.97% |
| 2015-03-31 | $0.07B | $0.02B | 22.22% |
| 2014-12-31 | $0.07B | $0.02B | 21.74% |
| 2014-09-30 | $0.06B | $0.01B | 21.88% |
| 2014-06-30 | $0.06B | $0.01B | 20.69% |
| 2014-03-31 | $0.05B | $0.01B | 22.64% |
| 2013-12-31 | $0.05B | $0.01B | 26.00% |
| 2013-09-30 | $0.05B | $0.01B | 25.00% |
| 2013-06-30 | $0.05B | $0.01B | 25.53% |
| 2013-03-31 | $0.05B | $0.01B | 25.53% |
| 2012-12-31 | $0.05B | $0.01B | 24.44% |
| 2012-09-30 | $0.04B | $0.01B | 27.27% |
| 2012-06-30 | $0.04B | $0.01B | 28.57% |
| 2012-03-31 | $0.04B | $0.01B | 30.00% |
| 2011-12-31 | $0.04B | $0.01B | 30.00% |
| 2011-09-30 | $0.04B | $0.01B | 28.95% |
| 2011-06-30 | $0.04B | $0.01B | 27.78% |
| 2011-03-31 | $0.03B | $0.01B | 26.47% |
| 2010-12-31 | $0.03B | $0.01B | 27.59% |
| 2010-09-30 | $0.03B | $0.01B | 30.77% |
| 2010-06-30 | $0.02B | $0.01B | 34.78% |
| 2010-03-31 | $0.02B | $0.01B | 38.10% |
| 2009-12-31 | $0.02B | $0.01B | 40.00% |
| 2009-09-30 | $0.02B | $0.01B | 40.00% |
| 2009-06-30 | $0.02B | $0.01B | 38.10% |
| 2009-03-31 | $0.02B | $0.01B | 38.10% |
| 2008-12-31 | $0.02B | $0.01B | 36.36% |
| 2008-09-30 | $0.02B | $0.01B | 36.36% |
| 2008-06-30 | $0.02B | $0.01B | 38.10% |
| 2008-03-31 | $0.02B | $0.01B | 40.00% |
| 2007-12-31 | $0.02B | $0.01B | 42.11% |
| 2007-09-30 | $0.02B | $0.01B | 38.89% |
| 2007-06-30 | $0.02B | $0.01B | 35.29% |
| 2007-03-31 | $0.02B | $0.01B | 29.41% |
| 2006-12-31 | $0.02B | $0.00B | 26.67% |
| 2006-09-30 | $0.01B | $0.00B | 28.57% |
| 2006-06-30 | $0.01B | $0.00B | 30.77% |
| 2006-03-31 | $0.01B | $0.00B | 36.36% |
| 2005-12-31 | $0.01B | $0.00B | 36.36% |
| 2005-09-30 | $0.01B | $0.00B | 36.36% |
| 2005-06-30 | $0.01B | $0.00B | 40.00% |
| 2005-03-31 | $0.01B | $0.00B | 36.36% |
| 2004-12-31 | $0.01B | $0.00B | 40.00% |
| 2004-09-30 | $0.01B | $0.00B | 44.44% |
| 2004-06-30 | $0.01B | $0.00B | 44.44% |
| 2004-03-31 | $0.01B | $0.00B | 50.00% |
| 2003-12-31 | $0.01B | $0.00B | 50.00% |
| 2003-09-30 | $0.01B | $0.00B | 50.00% |
| 2003-06-30 | $0.01B | $0.00B | 50.00% |
| 2003-03-31 | $0.01B | $0.00B | 50.00% |
| 2002-12-31 | $0.01B | $0.00B | 50.00% |
| 2002-09-30 | $0.01B | $0.00B | 50.00% |
| 2002-06-30 | $0.01B | $0.00B | 44.44% |
| 2002-03-31 | $0.01B | $0.00B | 44.44% |
| 2001-12-31 | $0.01B | $0.01B | 55.56% |
| 2001-09-30 | $0.01B | $0.01B | 55.56% |
| 2001-06-30 | $0.01B | $0.01B | 62.50% |
| 2001-03-31 | $0.01B | $0.01B | 62.50% |
| 2000-12-31 | $0.01B | $0.00B | 44.44% |
| 2000-09-30 | $0.01B | $0.00B | 44.44% |
| 2000-06-30 | $0.01B | $0.00B | 44.44% |
| 2000-03-31 | $0.01B | $0.00B | 44.44% |
| 1999-12-31 | $0.01B | $0.01B | 62.50% |
| 1999-09-30 | $0.01B | $0.01B | 75.00% |
| 1999-06-30 | $0.01B | $0.01B | 87.50% |
| 1999-03-31 | $0.01B | $0.01B | 100.00% |
| 1998-12-31 | $0.01B | $0.01B | 100.00% |
| 1998-09-30 | $0.01B | $0.01B | 100.00% |
| 1998-06-30 | $0.01B | $0.01B | 100.00% |
| 1998-03-31 | $0.01B | $0.01B | 100.00% |
| 1997-12-31 | $0.01B | $0.01B | 100.00% |
| 1997-09-30 | $0.01B | $0.01B | 100.00% |
| 1997-06-30 | $0.01B | $0.01B | 87.50% |
| 1997-03-31 | $0.01B | $0.01B | 87.50% |
| 1996-12-31 | $0.01B | $0.01B | 87.50% |
| 1996-09-30 | $0.01B | $0.01B | 75.00% |
| 1996-06-30 | $0.01B | $0.01B | 87.50% |
| 1996-03-31 | $0.01B | $0.01B | 62.50% |
| 1995-12-31 | $0.01B | $0.00B | 37.50% |
| 1995-09-30 | $0.01B | $0.00B | 25.00% |
| 1995-06-30 | $0.01B | 0 | 0.00% |
| 1995-03-31 | $0.01B | 0 | 0.00% |
| 1994-12-31 | $0.01B | 0 | 0.00% |
| 1994-09-30 | $0.01B | 0 | 0.00% |
| 1994-06-30 | $0.01B | 0 | 0.00% |
| 1994-03-31 | $0.01B | 0 | 0.00% |
| 1993-12-31 | $0.01B | $0.00B | 20.00% |
| 1993-09-30 | $0.00B | $0.00B | 25.00% |
| 1993-06-30 | $0.00B | $0.00B | 25.00% |
| 1993-03-31 | $0.00B | $0.00B | 50.00% |
| 1992-12-31 | $0.00B | $0.00B | 50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.418B | $0.241B |
| MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.059B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $200.747B | 78.54 |
| IDEXX Laboratories (IDXX) | United States | $56.571B | 56.18 |
| Edwards Lifesciences (EW) | United States | $48.391B | 32.45 |
| Alcon (ALC) | Switzerland | $36.485B | 24.49 |
| IQVIA Holdings (IQV) | United States | $35.841B | 19.99 |
| Mettler-Toledo (MTD) | United States | $29.649B | 34.40 |
| STERIS (STE) | Ireland | $25.888B | 26.72 |
| Waters (WAT) | United States | $22.128B | 29.27 |
| DexCom (DXCM) | United States | $21.451B | 29.57 |
| Hologic (HOLX) | United States | $16.481B | 17.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.721B | 0.00 |
| Globus Medical (GMED) | United States | $11.330B | 23.57 |
| Penumbra (PEN) | United States | $10.425B | 73.33 |
| Masimo (MASI) | United States | $7.690B | 24.64 |
| Sysmex ADR (SSMXY) | Japan | $6.698B | 21.28 |
| Teleflex (TFX) | United States | $4.835B | 7.70 |
| Glaukos (GKOS) | United States | $4.816B | 0.00 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.296B | 37.57 |
| Alphatec Holdings (ATEC) | United States | $2.941B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 14.88 |
| Integer Holdings (ITGR) | United States | $2.392B | 11.23 |
| Artivion (AORT) | United States | $2.117B | 97.54 |
| Nihon Kohden (NHNKY) | Japan | $2.067B | 24.67 |
| PROCEPT BioRobotics (PRCT) | United States | $1.784B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.686B | 16.34 |
| Beta Bionics (BBNX) | United States | $1.158B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.099B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.11 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.680B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.555B | 32.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.521B | 10.40 |
| AngioDynamics (ANGO) | United States | $0.495B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.437B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.427B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.418B | 3.28 |
| RxSight (RXST) | United States | $0.385B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.327B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Sight Sciences (SGHT) | United States | $0.305B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.294B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.265B | 0.00 |
| CVRx (CVRX) | United States | $0.255B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Neuronetics (STIM) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.54 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |